Skip To Main Content
Michelle Barron on Muck Rack

Michelle Barron

As seen in: Center for Disease Control and Prevention, Jacksonville Business Journal, JAMA Network, The New England Journal of Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michelle

Contact Michelle, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults

|
By Ryan Wiegand, Amanda Payne, Josephine Mak, Sean Chickery, Sarah Reese, Nicola P. Klein, Shaun Grannis, Toan C Ong, Elizabeth Rowley, Malini DeSilva, Kristin Dascomb, Stephanie A. Irving, Ousseny Zerbo, John Hansen, Lawrence Block, Karen B. Jacobson, Colin Rogerson, Thomas Duszynski, William F Fadel, Michelle Barron, David Mayer, Catia Chávez, Duck-Hye Yang, Sarah Ball Verified, Charlene E. McEvoy, Omobosola Akinsete, Tamara Sheffield, Daniel Bride, Julie Arndorfer, Allison L. Naleway, Karthik Natarajan, Morgan Najdowski, Allison Avrich Ciesla, Amber Kautz, Jennifer DeCuir, Ruth Link-Gelles, Joshua Van Otterloo
| JAMA Network Verified
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults Key Points Question What was the effectiveness of 2024-2025 COVID-19 vaccines against medically attended COVID-19 among adults 18 years and older in the US?
Open in Who Shared Issue with article?

Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design

|
By Ryan Wiegand, Sean Chickery, Duck-Hye Yang, Sarah Ball Verified, Malini DeSilva, Kristin Dascomb, Stephanie A. Irving, Karthik Natarajan, Nicola P. Klein, Shaun Grannis, Toan C Ong, Elizabeth Rowley, Adam Yates, Yan Zhuang Verified, Charlene E. McEvoy, Omobosola Akinsete, Allison L. Naleway, Padma Koppolu, Ousseny Zerbo, John Hansen, Karen B. Jacobson, Lawrence Block, Thomas Duszynski, Colin Rogerson, Michelle Barron, Catia Chávez, Josephine Mak, Allison Avrich Ciesla, Monica Godfrey, Morgan Najdowski, Ruth Link-Gelles, Jennifer DeCuir, Amanda Payne, Inih J. Essien, Amber Kautz
| JAMA Network Verified
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design Supplement 1. eTable 1. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) used to define COVID-19-like illness eTable 2. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) used to define underlying medical condition and immunocompromise status Supplement 2. Table 1.
Open in Who Shared Issue with article?

Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza Season

|
By Eduardo Azziz-Baumgartner, Alicia Budd, Justin Lee Verified, A. Danielle Iuliano, Sascha R. Ellington, Min Z. Levine, Xiao-Yu Zheng, Larisa Gubareva, Katherine Adams, Jennifer DeCuir, Catherine Bozio, Carrie Reed, Marie K. Kirby, Benjamin L Rambo-Martin, Jefferson M. Jones, Matthew Biggerstaff, Shikha Garg, Charles Davis, Tom T. Shimabukuro, Erin Burns, Rebecca Kondor, Sonja J. Olsen, Vivien G. Dugan, Stephanie A. Irving, Allison L. Naleway, Kristin Dascomb, Tamara Sheffield, Malini DeSilva, Sara Y. Tartof, Lina S. Sy, Nicola P. Klein, Ousseny Zerbo, Shaun Grannis, Melissa S. Stockwell, Ashley Stephens, Toan C Ong, Michelle Barron, Sarah Ball Verified, Zachary Weber, Emily Reeves, Caitlin Ray
| JAMA Network Verified
Supplement. Figure 1. Bar and Line Graph of Influenza-Positive Tests Reported to the Centers for Disease Control and Prevention by US Clinical Laboratories, National Summary, 2025-2026 Season (opens in new tab) The bars show the number of specimens positive for influenzas A and B, while lines show the percentage of positive specimens. Figure 2.
Open in Who Shared Issue with article?
See all 7 licensed articles (12 Total)